Another two... [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-16 23:41 (82 d 12:09 ago) – Posting: # 22575
Views: 1,619

Dear all,

It looks like the FDA has just keelhauled 2 CROs again: Panexcell and Synchron Research. The FDA will reject all data from both CROs due to data manipulation. All Panexcell data had already been rejected in the EU.

The FDA letters are very explicit regarding what they have found, and their conclusion is crystal clear:

Put simply, because you have been responsible for the creation of false data in the studies discussed here, we have no reason to believe that any data that you have produced are reliable. Thus, FDA has determined that all study data from all studies conducted at your firm must be rejected.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Wednesday 10:50 CET (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5